bosentan anhydrous has been researched along with Rheumatoid Arthritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bombonato-Prado, KF; Cunha, FQ; Cunha, TM; Donadi, EA; Donate, PB; Ferreira, SH; Junta, CM; Lima, FO; Louzada, P; Passos, GA; Peres, RS; Verri, WA; Vieira, SM | 1 |
1 other study(ies) available for bosentan anhydrous and Rheumatoid Arthritis
Article | Year |
---|---|
Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.
Topics: Adult; Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Bosentan; Cells, Cultured; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Female; Gene Expression Profiling; Humans; Leukocytes, Mononuclear; Lymph Nodes; Male; Methotrexate; Mice; Mice, Inbred DBA; Middle Aged; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Sulfonamides | 2012 |